ImpediMed

05/07/2026

This week marks National Nurses Week (May 6–12), led by the American Nurses Association and focused on The Power of Nurses.

Across healthcare, that power shows up in real, measurable ways—shaping how care is delivered, how patients are supported, and how outcomes continue to improve.

From bedside care to system-wide change, nurses are driving progress at every level.

See how organizations across the country are celebrating → https://pages.nursingworld.org/nursesweek26

Join us in celebrating National Nurses Week, May 6–12, 2026, and discover ways to recognize and support nurses everywhere.

05/06/2026

We’re at ASMBS Annual Meeting 2026 this week in San Antonio—joining the clinicians and researchers shaping what’s next in metabolic and bariatric care.

As the conversation continues to evolve beyond BMI, there’s growing focus on what’s actually changing beneath the surface—muscle, fat, and fluid—and how that impacts outcomes over time.

That’s where we’re spending our time this week.

—

Find us here:

📍 ASMBS Annual Meeting 2026 | San Antonio, TX | May 3–7 | Booth 1006

—

If you’d like to connect or schedule time:

🔗 https://www.impedimed.com/about/contact/

05/05/2026

May is Oncology Nursing Month, led by the Oncology Nursing Society and centered on this year’s theme: Growing Hope, Inspiring Strength.

It reflects the role oncology nurses play across the full patient journey—especially in survivorship, where progress is often gradual, complex, and closely managed over time.

That work continues long after a single visit or milestone. It’s built over time—through consistency, expertise, and close patient connection.

Learn more and explore ways to get involved → https://www.ons.org/membership/celebrate-oncology-nursing/oncology-nursing-month

05/02/2026

"Survivorship care means looking at the whole patient, not just the surgical outcome."
— David Weintritt, MD, FACS, Virginia Cancer Specialists

That perspective is at the heart of what ImpediMed is sharing at this week — an expanded vision for breast cancer survivorship that brings fluid status and body composition together with lymphedema surveillance, in a single longitudinal view.

Here's where to find us and these clinicians this week:

📍 Booth 308 — SOZO® Pro: the first and only FDA-cleared BIS for noninvasive lymphedema assessment, now with integrated body composition in a single 30-second scan

Full release: https://www.impedimed.com/impedimed-broadens-breast-cancer-survivorship-monitoring-with-the-sozo-digital-health-platform-at-asbrs-2026/

05/01/2026

ASBrS is underway in Seattle.

This meeting always brings together some of the most important conversations in breast cancer care—from surgical innovation to what happens next for patients after treatment.

Across sessions, there’s a clear focus on multidisciplinary care and long-term outcomes—how we support patients beyond treatment and into survivorship through lymphedema surveillance and body composition monitoring.

We’re here all week and would love to connect.

📍 Booth 308 | Seattle Convention Center

If you’d like to schedule time, you can reach us here: 🔗 https://www.impedimed.com/about/contact/

04/27/2026

There’s a difference between screening for lymphedema—and having a plan to act on what you find.

Leading programs are moving beyond one-time measurements toward a more consistent approach to surveillance:

• Establish a baseline
• Monitor routinely
• Act on early change
• Treat before progression

Because when lymphedema is identified at the subclinical stage, intervention is simpler—and in many cases, progression can be avoided.

If you’re working on building or refining this kind of approach, we’ll be at both ASBrS and ALA this month and would welcome the conversation.

—
Find us here:

📍 ASBrS 2026 | Seattle, WA | April 29 – May 3 | Booth 308

📍 ALA Conference 2026 | Cairns, Australia | May 1 – 3
—

If you’d like to connect or schedule time:
🔗 https://www.impedimed.com/about/contact/

04/22/2026

A “wait and see” approach doesn’t work for lymphedema.

In this interview with CURE®, Dr. Sheri Prentiss shares how her own experience with breast cancer-related lymphedema reshaped her view of survivorship care — and why early risk assessment matters.

Symptoms can take months or even years to appear. By the time they’re visible, the impact on quality of life, function, and long-term management can already be significant.

Shifting toward earlier assessment and shared decision-making isn’t just a clinical change — it changes the trajectory of survivorship.

Read the full article: https://www.impedimed.com/expert-dr-sheri-prentiss-discusses-early-lymphedema-risk-assessment/

04/17/2026

When body composition changes over time, the question isn’t just what changed—it’s how to interpret it.

Fluid shifts can occur early and can influence how changes in fat and muscle appear, especially when tracking progress longitudinally.

That’s why separating intracellular and extracellular fluid is important—so changes in tissue can be understood in the right context, not in isolation.

👉 Learn how BIS supports more precise body composition analysis:
https://www.impedimed.com/products/tissue-fluid-applications/body-composition-analysis/

04/13/2026

Lymphedema care is becoming more proactive—and more precise.

We were in Columbus last week at the World Symposium for Lymphedema Surgery, where the focus is on what it takes to prevent, identify, and treat lymphedema earlier—across surgery, therapy, and long-term survivorship care.

As surgical approaches continue to advance, there’s increasing emphasis on how patients are monitored over time, and how early physiologic changes can inform intervention before symptoms progress.